Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today
Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today

We deliver Mobile Wallet Market Research and SWOT Analysis from Alternative Energy to Pharmaceuticals and Healthcare Market Research Reports to Digital Media.

Skip to Main Content »

Search Site
Researchers Currently Online:819

ImClone LLC - Strategic SWOT Analysis Review

ImClone LLC - Strategic SWOT Analysis Review

Double click on above image to view full picture

Zoom Out
Zoom In
Additional Information
Price $125.00
Meta Description ImClone LLC (ImClone) is a biopharmaceutical company. It undertakes the development and manufacturing of targeted biologic treatments for cancer. The company's product pipeline has several investigational monoclonal antibodies in various stages of clinica
Publisher GlobalData
Date of Report Dec 3, 2013
Quick Overview
Summary

ImClone LLC (ImClone) is a biopharmaceutical company. It undertakes the development and manufacturing of targeted biologic treatments for cancer. The company's product pipeline has several investigational monoclonal antibodies in various stages of clinical development targeting a variety of cancers. The company has several investigational monoclonal antibodies in various stages of clinical development. It has built a novel pipeline of product candidates to address specific genetic mechanisms involved in cancer growth and development. The company operates as a wholly owned subsidiary of Eli Lilly and Company. It also operates a research facility in New York, the US.

GlobalData’s ImClone LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Note: Some sections may be missing if data is unavailable for the company.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Section 1 - About the Company 4
ImClone LLC - Key Facts 4
ImClone LLC - Key Employees 5
ImClone LLC - Major Products and Services 6
ImClone LLC - Pharmaceutical Pipeline Products Data 7
ImClone LLC, Pipeline Products by Therapy Area 7
ImClone LLC, Pipeline Products by Development Phase 8
ImClone LLC - History 10
ImClone LLC - Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 – Company Analysis 13
ImClone LLC - Business Description 13
ImClone LLC - SWOT Analysis 14
SWOT Analysis - Overview 14
ImClone LLC - Strengths 14
Strength - Expertise In-house Research Activities 14
Strength - Robust Manufacturing facility 14
Strength - Synergy through Eli Lilly 14
ImClone LLC - Weaknesses 14
Weakness - Failures of Clinical Trials 14
ImClone LLC - Opportunities 15
Opportunity - Strong Product Pipeline 15
Opportunity - Biotech Focus 15
Opportunity - Changing Demographics 15
ImClone LLC - Threats 15
Threat - Stringent Government Regulations 15
Threat - Competitive Pressures 16
Threat - Uncertain R&D Outcomes 16
ImClone LLC - Key Competitors 17
Section 3 – Company’s Lifesciences Financial Deals and Alliances 18
ImClone LLC, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 18
ImClone LLC, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 19
ImClone LLC, Recent Deals Summary 20
Section 4 – Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
ImClone LLC, Key Facts 4
ImClone LLC, Key Employees 5
ImClone LLC, Major Products and Services 6
ImClone LLC, Number of Pipeline Products by Therapy Area 7
ImClone LLC, Number of Pipeline Products by Development Stage 8
ImClone LLC, Pipeline Products By Therapy Area and Development Phase 9
ImClone LLC, History 10
ImClone LLC, Other Locations 12
ImClone LLC, Subsidiaries 12
ImClone LLC, Key Competitors 17
ImClone LLC, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 18
ImClone LLC, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 19
ImClone LLC, Recent Deals Summary 20

List of Figures
ImClone LLC, Pipeline Products by Therapy Area 7
ImClone LLC, Pipeline Products by Development Phase 8
ImClone LLC, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 18
ImClone LLC, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013 19




...